Literature DB >> 35637429

Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma.

Heng Ma1, Peng-Hui Feng2, Shuang-Ni Yu1, Zhao-Hui Lu1, Qi Yu3, Jie Chen4.   

Abstract

Entities:  

Year:  2022        PMID： 35637429      PMCID： PMC9153199          DOI： 10.1186/s12885-022-09692-0

Source DB:  PubMed          Journal:  BMC Cancer        ISSN： 1471-2407            Impact factor:   4.638


× No keyword cloud information.
  1 in total

1.  Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma.

Authors:  Heng Ma; Peng-Hui Feng; Shuang-Ni Yu; Zhao-Hui Lu; Qi Yu; Jie Chen
Journal:  BMC Cancer       Date:  2022-05-13       Impact factor: 4.638
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.